Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity
about
Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cellsHow Follicular Dendritic Cells Shape the B-Cell AntigenomeThe Unspecific Side of Acquired Immunity Against Infectious Disease: Causes and ConsequencesHow specific is too specific? B-cell responses to viral infections reveal the importance of breadth over depthAn AGM model for changes in complement during pregnancy: neutralization of influenza virus by serum is diminished in late third trimesterThe structural immunology of antibody protection against West Nile virusThe Paramyxoviruses Simian Virus 5 and Mumps Virus Recruit Host Cell CD46 To Evade Complement-Mediated NeutralizationAntibodies against viruses: passive and active immunizationInnate immunity to influenza virus: implications for future therapyComplement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanismComplement and its role in protection and pathogenesis of flavivirus infectionsInfluenza virus-like particles containing M2 induce broadly cross protective immunityVirus-like particle vaccine protects against 2009 H1N1 pandemic influenza virus in miceProtective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particlesSynergy between the classical and alternative pathways of complement is essential for conferring effective protection against the pandemic influenza A(H1N1) 2009 virus infection.A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infectionNovel vaccines against influenza viruses.A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors.Effect of priming with H1N1 influenza viruses of variable antigenic distances on challenge with 2009 pandemic H1N1 virus.Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury.Surviving mousepox infection requires the complement systemStabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skinB cells are not essential for Lactobacillus-mediated protection against lethal pneumovirus infection.Multiple components contribute to ability of saliva to inhibit influenza virusesInhibitors of C5 complement enhance vaccinia virus oncolysis.Complement Evasion Strategies of Viruses: An Overview.Detection of bacterial-reactive natural IgM antibodies in desert bighorn sheep populations.Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection.The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans.Down-regulation of complement receptors on the surface of host monocyte even as in vitro complement pathway blocking interferes in dengue infection.Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.Sustained viral load and late death in Rag2-/- mice after influenza A virus infection.Direct complement restriction of flavivirus infection requires glycan recognition by mannose-binding lectin.Complement and viral pathogenesisInfluenza M2 virus-like particles confer a broader range of cross protection to the strain-specific pre-existing immunityPhage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogensClearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complementCooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.Deletion of the complement C5a receptor alleviates the severity of acute pneumococcal otitis media following influenza A virus infection in mice.Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity.
P2860
Q21562507-B50D73DE-87DF-4079-949B-F510D7CC3940Q26742173-20FC60A9-5CB4-4761-A913-E0E6486A4E0BQ26770395-E7434C0B-FB9C-4B03-AF4B-DBF6A4141A51Q27026728-57565D3C-3DE7-4256-A1E8-7364EEBD441FQ27326934-8DF5400F-27FF-4F0C-8949-51649A5A8B44Q27487955-E7C42E20-AB8A-4E16-9B38-8054A6C4CB17Q27488882-52B6F910-E93A-4440-A78F-BA09D27C3ED6Q27489392-244CF466-9A27-4622-926C-60C733C7C815Q27489605-5F6DBB87-7946-4A9A-94E0-A74016574B2FQ27489809-159E2EDC-D27B-4FD0-8A58-DDD8DF4E5BF0Q27490236-FCC8CFE1-6AA4-44B1-918C-54C20B7E2F6CQ28743472-B8C84A33-5870-45BB-B997-E24F0C74E624Q28748950-8FB0CDBD-86A1-41B5-9095-4B1A89B8A213Q30390753-476B9E5A-543C-473F-9C24-47FC5D4A811BQ30399993-DED4D1AE-6506-40A5-822A-B7DE75391BF3Q30400787-4F16B491-D339-4A8E-95E3-987D3CB4CEEEQ30407716-297BA9BD-F1D0-4ED8-AFDA-A8886A629702Q30416451-68D77EE1-1E45-4310-A530-2199AD81A5AAQ30417675-2A7552F2-CF27-4938-8365-66E16D8C8ECDQ30430891-52499194-2CE4-4FEA-B632-7A840AA22CB8Q33396210-EF59F335-6247-4168-BA4E-27656BC076D4Q33506637-FC19F048-7DE7-469B-BE8E-99783F807571Q33638936-5BD9EF79-9CE6-4D46-8F31-17DA4C50143CQ33765207-1BEFD7BD-1A63-498E-9974-0100D1CCB4CFQ33768177-261E66F6-BC18-4643-A050-830D7B1D24C0Q33804431-DBD5ABEB-DE65-4C8C-B5F1-E9C50F93A26FQ33853621-505A077D-0C56-4535-8B59-7E84D46F0966Q33870745-20173647-62B8-43C1-AB82-90930A3A0C4BQ33912345-B049C6F1-4749-435C-A247-94B0F18A4BCDQ33951623-DFA3CD0A-5804-452F-BC98-A17A18E26A40Q33964159-E17D19F4-76D7-4879-8A28-4DFAB7842C68Q34057331-B664B0FB-BD4A-4302-81D1-0CF049AEF3CFQ34089838-EC2891AB-BD47-4217-84EA-BA4557CD0AD7Q34162421-37A2B509-9194-4146-9437-FB9C4E8B205BQ34254359-FD9E21DE-8F9C-4FA0-AC10-9EB0E96D1A67Q34401573-BEB723B1-0A7C-4669-8CFA-74A957E76D5BQ34597583-FF4C92B5-135D-4A98-9CBB-122723C52625Q34629133-756340CF-F6A3-4187-90E2-C1332DB4C012Q35150544-17CE8DAB-9763-4ED1-B5F4-84924B101655Q35151690-8C13DFEB-7150-44CA-8E70-EBCA063958C9
P2860
Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Natural antibody and complemen ...... the absence of prior immunity
@ast
Natural antibody and complemen ...... the absence of prior immunity
@en
Natural antibody and complemen ...... the absence of prior immunity
@nl
type
label
Natural antibody and complemen ...... the absence of prior immunity
@ast
Natural antibody and complemen ...... the absence of prior immunity
@en
Natural antibody and complemen ...... the absence of prior immunity
@nl
prefLabel
Natural antibody and complemen ...... the absence of prior immunity
@ast
Natural antibody and complemen ...... the absence of prior immunity
@en
Natural antibody and complemen ...... the absence of prior immunity
@nl
P2093
P2860
P3181
P356
P1433
P1476
Natural antibody and complemen ...... the absence of prior immunity
@en
P2093
E Ashley Moseman
Jerome P Jayasekera
Michael C Carroll
P2860
P304
P3181
P356
10.1128/JVI.02128-06
P407
P577
2007-04-01T00:00:00Z